Pik3ca mutations significantly enhance the growth of SHH medulloblastoma and lead to metastatic tumour growth in a novel mouse model
- 26 February 2020
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 477, 10-18
- https://doi.org/10.1016/j.canlet.2020.02.028
Abstract
No abstract availableKeywords
Funding Information
- Fördergemeinschaft Kinderkrebs-Zentrum Hamburg
- Erich und Gertrud Roggenbuck-Stiftung
- Deutsche Krebshilfe
This publication has 49 references indexed in Scilit:
- Novel mutations target distinct subgroups of medulloblastomaNature, 2012
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasActa Neuropathologica, 2012
- Clonal selection drives genetic divergence of metastatic medulloblastomaNature, 2012
- A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial CarcinomasClinical Cancer Research, 2011
- Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in MedulloblastomaScience Translational Medicine, 2010
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449The New England Journal of Medicine, 2009
- Acquisition of Granule Neuron Precursor Identity Is a Critical Determinant of Progenitor Cell Competence to Form Shh-Induced MedulloblastomaCancer Cell, 2008
- In vivo 3D digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopyFrontiers in Neuroanatomy, 2008
- A Novel Somatic Mouse Model to Survey Tumorigenic Potential Applied to the Hedgehog PathwayCancer Research, 2006
- Math1 Is Expressed in Temporally Discrete Pools of Cerebellar Rhombic-Lip Neural ProgenitorsNeuron, 2005